Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

ASX/ACL stock hub

ASX/ACL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/ACLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

358.4M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/ACL

In the news

Latest news · ASX/ACL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.1

P25 12.9P50 20.4P75 41.2

Trailing P/E13.6

P25 14.2P50 19.2P75 35.1

ROE16.7

P25 -118.7P50 -49.4P75 -1.2

ROIC9.9

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/ACL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

AUD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	4,700
Employees Change	-200%
Employees Change Percent	-4.08
Enterprise value	AUD 650.9M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	AU0000148496
Last refreshed	2026-05-10
Market cap	AUD 358.4M
Price	AUD 1.92
Price currency	AUD
Rev Per Employee	156,912.98x
Sector	Healthcare
Sic	8071
Symbol	asx/ACL
Website	https://www.clinicallabs.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.34%
EV Earnings	24.74x
EV/EBIT	9.48x
EV/EBITDA	3.2x
EV/FCF	4.15x
EV/Sales	0.88x
FCF yield	43.72%
Forward P/E	11.12x
P/B ratio	2.37x
P/E ratio	13.62x
P/S ratio	0.49x
PE Ratio10 Y	16.66x
PE Ratio3 Y	20.06x
PE Ratio5 Y	22.86x
PEG ratio	2.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.31%
EBITDA Margin	11.06%
FCF margin	21.25%
Gross margin	36.63%
Gross Profit	AUD 270.2M
Gross Profit Growth	-0.25%
Gross Profit Growth Q	-0.53%
Gross Profit Growth3 Y	2.08%
Gross Profit Growth5 Y	1.43%
Net Income	AUD 26.3M
Net Income Growth	-14.22%
Net Income Growth Q	-52.36%
Net Income Growth Years	1%
Net Income Growth3 Y	3.21%
Net Income Growth5 Y	-6.03%
Pretax Margin	5.64%
Profit Margin	3.57%
Profit Per Employee	AUD 5,598
Profitable Years	6
ROA	7.48
Roa5y	14.06
ROCE	18.78
ROE	16.68
Roe5y	48.78
ROIC	9.94
Roic5y	21.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-36.77%
Cagr3y	-15.08%
Div CAGR3	-35.72%
EPS Growth	-8.21
EPS Growth Q	-50.61
EPS Growth Years	1
EPS Growth3 Y	5.51
EPS Growth5 Y	-4.61
FCF Growth	-2.35%
FCF Growth Q	-22.95%
FCF Growth3 Y	0.78%
FCF Growth5 Y	2.76%
OCF Growth	-1.55%
OCF Growth Q	-22.48%
OCF Growth3 Y	1.03%
OCF Growth5 Y	2.75%
Revenue Growth	1.27x
Revenue Growth Q	-1.02x
Revenue Growth Years	1x
Revenue Growth3 Y	1.93x
Revenue Growth5 Y	1.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 1.29
Assets	AUD 562.5M
Cash	AUD 23.1M
Current Assets	AUD 115.5M
Current Liabilities	AUD 196.9M
Debt	AUD 315.1M
Debt EBITDA	AUD 1.55
Debt Equity	AUD 2.09
Debt FCF	AUD 2.01
Equity	AUD 151M
Interest Coverage	4.77
Liabilities	AUD 411.5M
Long Term Assets	AUD 447M
Long Term Liabilities	AUD 214.5M
Net Cash	AUD -292M
Net Cash By Market Cap	AUD -81.46
Net Debt EBITDA	AUD 3.58
Net Debt Equity	AUD 1.93
Net Debt FCF	AUD 1.86
Tangible Book Value	AUD -14.5M
Tangible Book Value Per Share	AUD -0.08
WACC	6.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.59
Inventory Turnover	28.26
Net Working Capital	AUD -267,000
Quick ratio	0.42
Working Capital	AUD -81.5M
Working Capital Turnover	AUD -8.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	6.51%
Dividend Growth	2%
Dividend Growth Years	1%
Dividend per share	AUD 0.13
Dividend Years	5
Dividend Yield	6.51%
Ex Div Date	2026-03-12
Last Dividend	AUD 0.04
Payout Frequency	Semi-Annual
Payout Ratio	92.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-36.75%
200-day SMA	2.48
3Y total return	-38.76%
50-day SMA	2.04
50-day SMA vs 200-day SMA	50under200
All Time High	6.39
All Time High Change	-69.95%
All Time High Date	2021-12-29
All Time Low	1.87
All Time Low Change	2.67%
All Time Low Date	2026-04-30
ATR	0.05
Beta	0.82
Beta1y	0.65
Beta2y	0.51
Ch YTD	-30.18
High	1.96
High52	3.24
High52 Date	2025-05-08
High52ch	-40.74%
Low	1.91
Low52	1.87
Low52 Date	2026-04-30
Low52ch	2.67%
Ma50ch	-5.88%
Price vs 200-day SMA	-22.67%
RSI	39.18
RSI Monthly	36.61
RSI Weekly	29.93
Sharpe ratio	-1.25x
Sortino ratio	-1.51
Total Return	13.02%
Tr YTD	-28.95
Tr1m	-6.34%
Tr3m	-24.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD 68.6M
Operating Income Growth	0.94
Operating Income Growth Q	2.35
Operating Income Growth3 Y	3.15
Operating Income Growth5 Y	1.03
Operating margin	9.31

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	169,524,608%
Net Borrowing	-105,247,000
Shares Insiders	2.65%
Shares Institutions	109.78%
Shares Out	186,674,968
Shares Qo Q	9.03%
Shares Yo Y	-6.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD 153.3M
Average Volume	737,679x
Bv Per Share	0.79
CAPEX	AUD -7.9M
Ch1m	-6.34
Ch1y	-39.81
Ch3m	-25.58
Ch3y	-45.92
Ch6m	-24.71
Change	0.52%
Change From Open	-1.79
Close	1.91
Days Gap	2.36
Depreciation Amortization	12,933,000
Dollar Volume	386,423
Earnings Date	2026-08-26
EBIT	AUD 68.6M
EBITDA	AUD 81.6M
EPS	AUD 0.14
F Score	7
FCF	AUD 156.7M
FCF EV Yield	24.08x
FCF Per Share	AUD 0.84
Financing CF	-154,653,000
Fiscal Year End	June
Founded	2,020
Graham Number	1.58028
Graham Upside	-17.69
Income Tax	AUD 14.9M
Investing CF	-8,324,000
Is Primary Listing	1
Last Earnings Date	2026-02-16
Last Report Date	2025-12-31
Lynch Fair Value	AUD 0.7
Lynch Upside	-63.29
Ma150	2.43
Ma150ch	-21.05%
Ma20	1.97
Ma20ch	-2.64%
Net CF	1,619,000
Next Earnings Date	2026-08-26
Open	1.96
P FCF Ratio	2.29
P OCF Ratio	2.18
Payment Date	2026-03-31
Position In Range	22.22
Ppne	262,234,000
Price Date	2026-05-08
Price EBITDA	AUD 4.39
Relative Volume	0.27x
Revenue	737,491,000x
SBC By Revenue	0.47x
Share Based Comp	3,442,000
Tax By Revenue	2.02x
Tax Rate	35.87%
Tr6m	-23.38%
Volume	201,262
Z Score	2.76

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ASX/ACL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+6.5%

$0.13 annual per share

Payout ratio

+92.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+13.0%

Next ex-dividend date: 2026-03-12

Performance

ASX/ACL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/ACL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+109.8%

Share of float held by funds and institutions

Insider ownership

+2.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-6.5%

Negative means the company is buying back shares.

Technical

ASX/ACL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.2

Neutral momentum band

Price vs 200-day MA

-22.7%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

-1.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/ACL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/ACL stock rating?

asx/ACL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/ACL analysis?

The full report lives at /stocks/asx/ACL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/ACL?

The latest report frames asx/ACL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/ACL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.